Pandemics and highly infectious diseases were a key concern in 2020 in the wake of the global outbreak of COVID-19. At this point in time our research suggests that outcomes for individuals managing cystic fibrosis (CF) who also contract COVID-19 are comparable to the general population, however this may change in the light of larger sample sizes and virus mutations as time goes on.

On a personal level we are hoping for a quick rollout of the COVID-19 vaccine so that risk to the CF community can be mitigated as much as possible. There is certainly an overlap between the organs and system affected by the symptoms of COVID-19 and those affected by cystic fibrosis.

In the ongoing wake of the COVID crisis, we advocate increased public health and hygiene measures as well as a wider culture of social distancing. 

It is possible that positive practices and habits can be formed in this uncertain time, and individuals who live with CF would be better looked after by our society if germ management and anti-infection measures became a part of the national routine.

For certain aspects of healthcare and consultation, telehealth seems to be an emerging innovation that can reduce risks and ensure that those managing CF are within reach of equitable care.

Additional Resources

CF and Infectious disease:



Talk to us

Have any questions? We are always open to talk about your business, new projects, creative opportunities and how we can help you.

Scroll to Top